MK0952

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0952, covering 2016-05-16 to 2016-05-16. Get the full timeline:

Most recent: Clinical Trial Update: MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED) [Phase 2]